Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 575.8420 ↓ -0.33%
[as on 5 December, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option -1.86% -0.33% -0.91% -0.35% 0.57% 0.37% 22.07% 17.19% 20.33% 14.49%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.67% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.33%

Equity

NameSymbol / ISINSectorWeight %QuantityQty change %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.67%6256349-
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.07%1000031-
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology7.26%3083991-
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.29%3495054-
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.97%648795-
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.62%3916074-
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.42%2886684-
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.32%3627277-
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology3.05%1320549-
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.87%913226-
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology2.83%959323-
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.81%2555745-
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.59%1548692-1.53%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.39%68677-
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.32%1702630-
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.29%609112-
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.16%757496-
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.14%323678-
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology2.10%4719374-
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.01%999649-
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.99%318249-
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.95%923911-10.23%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.50%984838+20.10%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.48%3896349-
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.35%1103889-
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology1.32%230272-
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.24%213659-
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services1.23%891340-
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.00%1280492-
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.90%1058503-
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.84%1515264-
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology0.74%470272-
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.72%62568-
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.61%1834924-
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology0.43%492727-
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.19%111738-
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV history

DateNAV
5 December, 2025575.8420
4 December, 2025577.7651
3 December, 2025574.9782
2 December, 2025576.1078
1 December, 2025576.9573
28 November, 2025581.1187
27 November, 2025578.3367
26 November, 2025579.6740
25 November, 2025575.2235
24 November, 2025573.7256
21 November, 2025575.7811
20 November, 2025578.1089
19 November, 2025579.3228
18 November, 2025578.4590
17 November, 2025582.2375
14 November, 2025579.9792
13 November, 2025577.9789
12 November, 2025575.3141
11 November, 2025570.5733
10 November, 2025572.3607
7 November, 2025570.7980
6 November, 2025574.0441
4 November, 2025577.8362
3 November, 2025579.4970
31 October, 2025571.8029
30 October, 2025573.5529
29 October, 2025576.1216
28 October, 2025571.9440
27 October, 2025573.1177
24 October, 2025573.9228

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 575.8420 as on 5 December, 2025.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -1.86% as on 5 December, 2025.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 0.37% as on 5 December, 2025.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 22.07% as on 5 December, 2025.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 17.19% as on 5 December, 2025.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 17.19% as on 5 December, 2025.